GS-441524 is the main plasma metabolite of the antiviral prodrug remdesivir, and has a half-life of around 24 hours in human patients. Remdesivir and GS-441524 were both found to be effective in vitro against feline coronavirus strains responsible for feline infectious peritonitis (FIP), a lethal systemic disease affecting domestic cats.
Attributes | Details |
---|---|
Product Name | GS-441524 Tablets |
Storage | Store At 2°C To 20°C |
Grade | Pharmaceutcial Grade |
Active Ingredient | GS-441524 |
CAS | 1191237-69-0 |
Form | Tablets |
Specification | 20mg/tablets, 40mg/tablets, Or Customized |
Packaging | 10 Tablets Per Bag |
12 months | 12 Months |
Route of Administration | Intramuscular Or Subcutaneous |